$14.35
-0.22-1.51%
At close: -
$14.35
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Keros Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:KROS | Benzinga
Keros Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS
$3.620
Quarterly Revenue
$211.25M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$214.71M
Analyze the earnings history of Keros Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics | -$1.25 | — | — | — | $37.00K | — | — | — | 08/06/2025 | Get Alert |
| KROS | Keros Therapeutics | -$1.21 | $0.01 | $3.62 | 36100.00% | $83.00K | $56.65M | $211.25M | 272.90% | 05/06/2025 | Get Alert |
| KROS | Keros Therapeutics | -$1.34 | -$0.96 | -$1.14 | -18.75% | $143.00K | — | $3.04M | — | 02/26/2025 | Get Alert |
| KROS | Keros Therapeutics | -$1.33 | -$1.27 | -$1.41 | -11.02% | $8.00K | — | $388.00K | — | 11/06/2024 | Get Alert |
| KROS | Keros Therapeutics | -$1.27 | -$1.23 | -$1.25 | -1.63% | $0.00 | — | $37.00K | — | 08/07/2024 | Get Alert |
| KROS | Keros Therapeutics | -$1.26 | -$1.34 | -$1.21 | 9.70% | $0.00 | — | $83.00K | — | 05/08/2024 | Get Alert |
| KROS | Keros Therapeutics | -$1.09 | -$1.37 | -$1.34 | 2.19% | $0.00 | — | $143.00K | — | 02/28/2024 | Get Alert |
| KROS | Keros Therapeutics | -$0.92 | -$1.35 | -$1.33 | 1.48% | $0.00 | — | $8.00K | — | 11/06/2023 | Get Alert |
| KROS | Keros Therapeutics | -$1.13 | -$1.34 | -$1.27 | 5.22% | $0.00 | $220.00K | $0.00 | -100.00% | 08/07/2023 | Get Alert |
| KROS | Keros Therapeutics | -$1.01 | -$1.12 | -$1.26 | -12.50% | $0.00 | $220.00K | $0.00 | -100.00% | 05/04/2023 | Get Alert |
| KROS | Keros Therapeutics | -$0.30 | -$1.10 | -$1.09 | 0.91% | $20.00M | $860.00K | $0.00 | -100.00% | 03/03/2023 | Get Alert |
| KROS | Keros Therapeutics | -$0.87 | -$1.23 | -$0.92 | 25.20% | $0.00 | — | $0.00 | — | 11/03/2022 | Get Alert |
| KROS | Keros Therapeutics | -$0.67 | -$1.06 | -$1.13 | -6.60% | $100.00K | — | $0.00 | — | 08/04/2022 | Get Alert |
| KROS | Keros Therapeutics | -$0.68 | -$0.86 | -$1.01 | -17.44% | $0.00 | — | $0.00 | — | 05/05/2022 | Get Alert |
| KROS | Keros Therapeutics | -$0.49 | -$0.94 | -$0.30 | 68.09% | $0.00 | — | $20.00M | — | 03/09/2022 | Get Alert |
| KROS | Keros Therapeutics | -$0.60 | — | -$0.87 | — | $0.00 | — | $0.00 | — | 11/04/2021 | Get Alert |
| KROS | Keros Therapeutics | -$0.62 | -$0.65 | -$0.67 | -3.08% | $0.00 | — | $100.00K | — | 08/05/2021 | Get Alert |
| KROS | Keros Therapeutics | -$5.11 | -$0.58 | -$0.68 | -17.24% | $0.00 | — | $0.00 | — | 05/06/2021 | Get Alert |
| KROS | Keros Therapeutics | -$1.32 | — | -$0.49 | — | — | — | $0.00 | — | 03/25/2021 | Get Alert |
| KROS | Keros Therapeutics | -$1.71 | — | -$0.60 | — | — | — | $0.00 | — | 11/10/2020 | Get Alert |
| KROS | Keros Therapeutics | -$1.44 | — | -$0.62 | — | — | — | $0.00 | — | 08/13/2020 | Get Alert |
Keros Therapeutics (KROS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-06 | $3.62 | $0.01 | 36100.0 % |
| Q4 | 2025-02-26 | $-1.14 | $-0.96 | -18.8 % |
| Q3 | 2024-11-06 | $-1.41 | $-1.27 | -11.0 % |
| Q2 | 2024-08-07 | $-1.25 | $-1.23 | -1.63 % |
Keros Therapeutics (KROS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-06 | $211.25M | $56.65M | 272.9 % |
| Q2 | 2023-08-07 | $0 | $220.00K | -100.0 % |
| Q1 | 2023-05-04 | $0 | $220.00K | -100.0 % |
| Q4 | 2023-03-03 | $0 | $860.00K | -100.0 % |
FAQ
When is Keros Therapeutics (NASDAQ:KROS) reporting earnings?
Keros Therapeutics (KROS) is scheduled to report earnings on August 6, 2025. The last reported earnings were for reported on May 6, 2025 for Q1.
What were the latest earnings per share (EPS) for Keros Therapeutics (NASDAQ:KROS)?
The Actual EPS was $3.62, which beat the estimate of $0.01.
What were Keros Therapeutics’s (NASDAQ:KROS) revenues?
The Actual Revenue was $211.2M, which beat the estimate of $56.6M.
Browse earnings estimates, EPS, and revenue on all stocks.
